Ophthalmology

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - Annual Meeting of the American Academy of Ophthalmology (AAO)

Optimizing Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration

New Orleans, Louisiana / November 16-19, 2013

New Orleans - Vascular Endothelial Growth Factor (VEGF) stimulates vascular endothelial cell growth and proliferation along with hyperpermeability of vessels. Anti-VEGF agents preserve and improve visual acuity by arresting choroidal...

MEDICAL FRONTIERS - Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

New Comparative Data for Anti-VEGF Therapies in Age-Related Macular Degeneration

Seattle, Washington / May 5-9, 2013

Seattle - A head-to-head trial failed to demonstrate that bevacizumab matches the efficacy and safety of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). For the primary end point of the trial, presented...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

ARVO Update: Evolving Strategies for Diabetic Macular Edema

Seattle, Washington / May 5-9, 2013

Guest Editor:  R. Geoff Williams, MD Southern Alberta Eye CenterCanada IntroductionAn ongoing evolution in the treatment of diabetic macular edema (DME) is being driven by an expansion of therapeutic options. At the 2013 Annual...

MEDICAL FRONTIERS - Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting

VEGF Inhibitor Treatment for Age-related Macular Degeneration

Fort Lauderdale, Florida / May 6-10, 2012

Fort Lauderdale - The controversy regarding the relative efficacy and safety of vascular endothelial growth factor inhibitors in the treatment of age-related macular degeneration was addressed but not resolved by 2 large, independent...

MEDI-NEWS - Based on: Lanzl I, Raber T. Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice. Clin Ophthalmol 2011;5:291-8.

Novel Combination Therapy for Intraocular Pressure: Achieving Greater Efficacy and Patient Satisfaction

May 2011

  Finding the Optimal Combination for Efficacy and Tolerability   Most individuals with elevated intraocular pressure (IOP) fail to achieve adequate control on a single agent. Over the past decade, the effort to incorporate 2...

PRIORITY PRESS - World Glaucoma Congress 2009

Modifying the Risk of Glaucoma Progression

Boston, Massachusetts / July 8-11, 2009

Boston - Glaucoma is a chronic progressive optic neuropathy that, without adequate management, can lead to irreversible visual loss and reduced quality of life. Because its risk and rate of progression varies considerably from patient to...

PRIORITY PRESS - 17th Congress of the European Society of Ophthalmology

New Data for the Comprehensive Management of Glaucoma

Amsterdam, The Netherlands / June 13-16, 2009

Amsterdam - An abundance of recent clinical studies demonstrates that abnormalities other than elevated intraocular pressure (IOP) play a substantial role in the development and progression of glaucoma. Yet some clinicians continue to...

FRONTLINE - Based on Sessions from the 64th Annual Meeting of the Canadian Rheumatology Association

Rheumatology

Kananaskis, Alberta / February 18-21, 2009

Spondyloarthropathies and Comorbidities: Enhancing Patient Care by Increasing Interspecialty Awareness Editorial Overview: Michel Zummer, MD, FRCPC Head, Division of Rheumatology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec The...

71st Annual Meeting & Exhibition of the Canadian Ophthalmological Society

The Glaucoma Triad: Intraocular Pressure, Blood Flow and Blood Pressure

Whistler, British Columbia / June 11-14, 2008

Whistler - Although intraocular pressure is an important parameter in the diagnosis and treatment of glaucoma, disease progression can take place in the presence of what may appear to be normal pressures. Factors responsible for this...

8th Congress of the European Glaucoma Society

Comprehensive Care for the Glaucoma Patient

Berlin, Germany / June 1-6, 2008

Berlin - Expert opinion has categorized increased intraocular pressure (IOP) and fluctuations of IOP as important risk factors for progression of glaucoma. The risk of sustained glaucomatous impairment increases proportionately as IOP...

PAGE 1 OF 2   1 2